USPTO serial 79148927
DMBIO Y
Reviewed by CopyMark Law Group
Reg. 4654830Status 404
- Filing date
- Status date
- Registration date
- Dec 16, 2014
- Examiner
- HOFFMAN, DAVID AARON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DMBIO Y?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KR
Tokyo 104-8002, JP
JP
JP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer | SECTION 71 - CANCELLED | — |
| 042 | Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceutical products | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DM Bio Limited
- Other trademarks owned by Meiji Seika Pharma Co., Ltd.
- Other trademarks owned by Meiji Seika Pharma Co., Ltd.
- Other trademarks owned by Meiji Seika Pharma Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named DMBIO Y
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 16, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 16, 2023 | FINP | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 24, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 24, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jan 24, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 30, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 2, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 2, 2021 | C71T | CANCELLED SECTION 71 | — |
| Dec 16, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 9, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 22, 2015 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 7, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 7, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 16, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 16, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 30, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 30, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 21, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 20, 2014 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 12, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 25, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 22, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 22, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 11, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |